# US 2010/0168007 A1 · Systems and Methods for Applying Cross-Linked Mechanical Barriers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168007 A1
- Document ID: US20100168007A1
- Status: Published application
- Kind: A1
- Application number: 12/460,267
- Filed: 2009-07-16
- Published: 2010-07-01
- Earliest claimed: 1998-08-26
- Assignees: NeoMend, Inc.
- Inventors: Gregory M. Cruise; Olexander Hnojewyj
- Web page: https://patentgrep.com/patent/US20100168007A1

## CPC

- A61B 17/00491: {Surgical glue applicators}
- A61B 17/0057: {Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect (sutures A61B17/04; closing rectum or urethra near body surface A61F2/0009)}
- A61B 50/30: Containers specially adapted for packaging, protecting, dispensing, collecting or disposing of surgical or diagnostic appliances or instruments (for wound clamps A61B17/10; for ligaturing clips A61B17/122; packages or dispensers for surgical gloves or finger-stalls A61B42/40)
- A61L 24/043: {Mixtures of macromolecular materials}
- A61B 2017/00495: {for two-component glue}
- A61B 2017/00637: {for sealing trocar wounds through abdominal wall}
- A61B 2017/0065: {the implement being an adhesive}
- A61B 2017/00654: {entirely comprised between the two sides of the opening}
- A61B 2017/00672: {Locating means therefor, e.g. bleed back lumen}
- A61B 2017/22069: {Immobilising; Stabilising}
- A61L 2430/36: for embolization or occlusion, e.g. vaso-occlusive compositions or devices
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

A delivery device applies a biocompatible and biodegradable barrier material to a tissue region, e.g., to seal a vascular puncture site. The material comprises two liquid components, which are pre-packaged in individual dispensers. Upon mixing, the liquid components cross-link to create a barrier matrix. A holder attaches to the delivery device. The holder mutually supports the first and second dispensers while the protein solution and polymer solution are conveyed from the dispensers into a fluid delivery channel. The protein and polymer solutions mix as a result of flow through the channel.

## Claims

### Claim 1

A biocompatible and biodegradable material applied to seal a vascular puncture comprising a mixture of protein solution and a polymer solution comprising poly(ethylene glycol)(PEG) with a functionality of at least three, wherein, upon mixing, the protein solution and the polymer solution cross link to form a solid matrix that seals the vascular puncture without use of a photo initiator and ultraviolet light energy.

### Claim 2 (depends on 1)

A material according to claim 1, wherein the protein solution has a pH value of between about 8 and about 10.

### Claim 3 (depends on 1)

A material according to claim 1, wherein the PEG has a molecular weight of between about 10,000 and 15,000 g/mole.

### Claim 4 (depends on 1)

A material according to claim 1, wherein the PEG comprises a multi armed polymer structure.

### Claim 5 (depends on 1)

A material according to claim 1, wherein PEG comprises a compound having the formula PEG (DCR CG)n, where PEG is poly(ethylene glycol), DCR is a degradation control region, CG is a cross linking group, and n is equal to or greater than three.

### Claim 6 (depends on 5)

A material according to claim 5, wherein the compound comprises a multi armed polymer structure.

### Claim 7 (depends on 5)

A material according to claim 5, wherein the PEG comprises a 4 arm PEG, the degradation control region comprises glutaric acid, and the cross linking group includes a N hydroxysuccinimide ester.

### Claim 8 (depends on 1)

A material according to claim 1, wherein the PEG has a functionality of four.

### Claim 9 (depends on 1)

A material according to claim 1, wherein the PEG has a concentration that ranges from about 5% to about 35% w/w.
